MidAmerica Cancer Care — Kansas City, Missouri

MidAmerica Cancer Care is a clinical research site located in Kansas City, Missouri, United States 64114.

Crixeo Health Trust Score: 65/100 (FAIR). This profile has not yet been claimed by the site owner.

MidAmerica Cancer Care has participated in 5 clinical trials with 2 currently active.

Therapeutic areas: Small-cell Lung Cancer, Squamous Cell Carcinoma of the Head and Neck, Advanced Melanoma.

Sponsors: EMD Serono Research & Development Institute, Inc., Eikon Therapeutics, Allogene Therapeutics.

Sponsor Feasibility Report

Trust Score: 65/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MidAmerica Cancer Care?

MidAmerica Cancer Care has a Crixeo Trust Score of 65/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MidAmerica Cancer Care conducted?

MidAmerica Cancer Care has 5 clinical trials on record, with 2 currently active. Their work covers Small-cell Lung Cancer, Squamous Cell Carcinoma of the Head and Neck, Advanced Melanoma.

Is MidAmerica Cancer Care accredited by Crixeo Health?

MidAmerica Cancer Care has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MidAmerica Cancer Care?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.